Please login to the form below

Not currently logged in
Email:
Password:

Senior appointments at NextPharma Technologies

Andrew Kelley, Pierre Delavaud and Matthew Wilder join the contract manufacturing organisation

Contract manufacturing organisation (CMO) NextPharma Technologies has added Andrew Kelley, Pierre Delavaud and Matthew Wilder to its senior team.

Kelley has been appointed chief operating officer of the Surrey, UK-based firm; Delavaud (pictured) will take over as executive VP sales and marketing; and Matthew Wilder joins as VP of US sales and marketing.

The most experienced new employee is Kelley. He has spent more than 27 years in the pharma industry and was recently VP of business development Europe and Asia-Pacific at Canada-based CMO Patheon.

Previous positions have included VP of European operations at Catalent and manufacturing manager at Boehringer Ingelheim.

Andrew Kelley - NextPharmaPierre Delavaud - NextPharmaMatthew Wilder - NextPharma
Andrew Kelley, Pierre Delavaud and Matthew Wilder

Delavaud joins NextPharma from SkyePharma where he had served as executive VP of sales and business development since September, 2011.

Prior to that he spent 14 years at Catalent serving in several senior positions, including VP of business development, global pharmaceutical softgel.

Wilder was most recently at Sanofi, where he had been for ten years, holding roles that included divisional sales manager and regional sales director.

Franck Latrille, NextPharma's CEO, said: “We are delighted to welcome our three new colleagues to our growing team at NextPharma. This is an exciting time for the company, and we are confident that with the injection of their expertise to the team, we can continue to improve our business offerings.”

4th September 2012

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Viseven

Viseven is a full cycle digital agency with 10 years expertise in developing content for the global pharmaceutical market delivering...

Latest intelligence

BRIC markets
BRIC markets
Why these countries offer an opportunity for pharma despite a slowdown...
Obstetrics Virtual Journal Club: An Impetus Digital Customer Success Story
Our online solutions are not just for advisory boards - find out how one client leveraged the Impetus InSite Platform® for a virtual journal club....
Ludovic Helfgott
Novo Nordisk awakens its ‘Sleeping Beauty’
Biopharm emerges from troubled times to hit ‘solid growth’, says executive vice president Ludovic Helfgott...

Infographics